FDA Approves Drug For Common Skin Cancer
On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's generic name is vismodegib and was developed by the US part of Roche Holding AG. It will be sold in the US by Roche's South San Francisco-based Genentech under the brand name Erivedge. Basal cell carcinoma is a slow ...

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX (teduglutide) for the Treatment of ...
NPS Pharmaceuticals, Inc. , a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced the U.S.